Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Boron Molecular is a specialist chemical manufacturer and contract research organization (CRO) that provides high-quality building blocks and custom synthesis services to the pharmaceutical, biotechnology, and materials science industries. Spun out of Australia's national science agency, CSIRO, in 2001, the company is globally recognized for its expertise in boron chemistry and Suzuki-Miyaura coupling. They offer an extensive catalog of boronic acids, esters, and other complex organic intermediates, alongside services in process development and scale-up from milligram to multi-kilogram quantities. With operations in Australia and the United States, Boron Molecular supports global drug discovery and development by providing critical chemical components and technical expertise.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Boron Molecular.